...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and bioactivity evaluation of 2,3-diaryl acrylonitrile derivatives as potential anticancer agents
【24h】

Synthesis and bioactivity evaluation of 2,3-diaryl acrylonitrile derivatives as potential anticancer agents

机译:2,3-二芳基丙烯腈衍生物作为潜在抗癌剂的合成与生物活性评价

获取原文
获取原文并翻译 | 示例

摘要

Thirty novel derivatives of 2,3-diaryl acrylonitrile were synthesized and evaluated for biological activity. Preliminary investigations of antitumor activity in vitro showed that most of the synthesized compounds have significant antiproliferative effects on human cancer cell lines, such as BEL-7402, HeLa, and HCT116 with IC50 values in the range of 0.13-60.23 mu lM without significant toxic effects on the non-cancerous human liver cell line L-02. In particular, compounds 4d and 4p were found to be the most potent against HeLa (4.20 mu M) and HCT116 cells (0.13 mu M), respectively, with superior or similar in vitro efficacy to that of the broad-spectrum anticancer drug taxol. (C) 2016 Published by Elsevier Ltd.
机译:合成2,3-二芳基丙烯腈的三十个新衍生物,并评估生物活性。 体外抗肿瘤活性的初步研究表明,大多数合成化合物对人癌细胞系具有显着的抗增殖作用,例如Bel-7402,Hela和Hct116,其IC50值在0.13-60.23μlmLm的范围内没有显着毒性作用 在非癌性人肝细胞系L-02上。 特别地,发现化合物4D和4P分别对Hela(4.20μm)和Hct116细胞(0.13μm)的最有效,具有优异的或类似的体外效率与广谱抗癌药物紫杉醇的体外效率。 (c)2016由elestvier有限公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号